Diversified Enterprises’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.82M Sell
5,682
-9
-0.2% -$9.2K 0.33% 33
2026
Q1
$5.23M Buy
5,691
+79
+1% +$80.1K 0.29% 35
2025
Q4
$6.03M Buy
5,612
+997
+22% +$953K 0.36% 33
2025
Q3
$3.52M Sell
4,615
-24
-0.5% -$17.9K 0.24% 43
2025
Q2
$3.62M Buy
4,639
+1
+0% +$777 0.27% 37
2025
Q1
$3.83M Buy
4,638
+572
+14% +$476K 0.32% 30
2024
Q4
$3.14M Buy
4,066
+118
+3% +$97.7K 0.3% 29
2024
Q3
$3.5M Buy
+3,948
New +$3.55M 0.38% 20

Other funds holding LLY

Diversified Enterprises's LLY Position: Q2 2026 in Review

Diversified Enterprises reduced its Eli Lilly (LLY) stake by 0.16% in Q2 2026, selling an estimated $9.2K and leaving 5,682 shares worth $6.82M. The position accounts for 0.33% of the portfolio, ranked #33.

Diversified Enterprises first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Diversified Enterprises held 5,682 shares of Eli Lilly worth $6.82M as of Q2 2026.
  • Diversified Enterprises sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.33% of Diversified Enterprises's portfolio in Q2 2026, its #33 holding.
  • Diversified Enterprises first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.